Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial

Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added, replacing the previous v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:47:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a metadata/version update with no changes to study content or public information.
    Difference
    0.0%
    Check dated 2026-03-18T19:42:20.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:43.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added a publication entry for the AIMS-2-TRIALS-CT1 study (EClinicalMedicine, 2026) under Publications, and included revision note v3.4.2.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:13.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with references to cc.nih.gov and opm.gov. Revision metadata updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:58:36.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Show glossary toggle added and glossary UI is now visible. QC metadata labels and revision info were updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).
    Difference
    0.2%
    Check dated 2026-01-28T04:19:27.000Z thumbnail image

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.